Long-term drift and timolol therapy: possible role for pulsed therapy
- PMID: 1428566
- DOI: 10.1007/BF00917984
Long-term drift and timolol therapy: possible role for pulsed therapy
Abstract
Eyes treated with a topical betablocker may exhibit the phenomenon of longterm drift, leading to loss of intraocular pressure control. It has been suggested that discontinuation of the betablocker may restore sensitivity to betablocker therapy, and that this phenomenon might be enhanced by the administration of an adrenergic agonist during this holiday period. This study was set up to examine further this hypothesis. Nine patients with ocular hypertension receiving treatment with timolol were entered into the study. Timolol was discontinued then re-started after four weeks of treatment with dipivefrin. This treatment cycle was repeated after a further four weeks. IOP was measured every two weeks. Re-introduction of timolol was associated with a significant lowering of IOP at two weeks (3.2 mmHg in the first cycle, p < 0.01, 3.4 mmHg in the second cycle, p < 0.01). Discontinuation of timolol and treatment with dipivefrin was not associated with a significant change in IOP.
Similar articles
-
Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.Invest Ophthalmol Vis Sci. 1996 Mar;37(4):684-8. Invest Ophthalmol Vis Sci. 1996. PMID: 8595970 Clinical Trial.
-
Restoring sensitivity to timolol after long-term drift in primary open-angle glaucoma.Invest Ophthalmol Vis Sci. 1990 Feb;31(2):354-8. Invest Ophthalmol Vis Sci. 1990. PMID: 2406218 Clinical Trial.
-
Is it worthwhile to add dipivefrin HCl 0.1% to topical beta 1-, beta 2-blocker therapy?Ophthalmology. 1989 Sep;96(9):1338-41; discussion 1341-2. Ophthalmology. 1989. PMID: 2571114 Clinical Trial.
-
Combined therapy of pilocarpine or latanoprost with timolol versus latanoprost monotherapy.Surv Ophthalmol. 2002 Aug;47 Suppl 1:S155-61. doi: 10.1016/s0039-6257(02)00329-6. Surv Ophthalmol. 2002. PMID: 12204713 Review.
-
Latanoprost : an update of its use in glaucoma and ocular hypertension.Drugs Aging. 2003;20(8):597-630. doi: 10.2165/00002512-200320080-00005. Drugs Aging. 2003. PMID: 12795627 Review.
Cited by
-
A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients.Graefes Arch Clin Exp Ophthalmol. 2004 Sep;242(9):767-70. doi: 10.1007/s00417-004-0866-2. Graefes Arch Clin Exp Ophthalmol. 2004. PMID: 15241611 Clinical Trial.